Department of Cell Biology, Global Research and Development, Ann Arbor Laboratories, Pfizer, Co, Ann Arbor, MI 48105, USA
* Author for correspondence (e-mail: Roman.Herrera{at}Pfizer.com )
Accepted 6 February 2002
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Treatment of MDCK cells with HGF leads to a time-dependent activation of SGK1 that is blocked by wortmanin. This activation requires the conserved phosphorylation site present in the activation loop of the kinase (T256 in SGK1) and the phosphorylation site present in a hydrophobic domain at its C-terminus (S422 in SGK1), which are targets for PDK1/PDK2-mediated regulation of SGK1. We tested whether SGK1 could be activated by cAMP as it contains a putative PKA site. We were unable to demonstrate a significant activation of HA-SGK1 by cAMP stimulation under conditions where we detect cAMP-mediated phosphorylation of the transcription factor CREB.
Cotransfection of SGK1 with activated small GTP-binding proteins revealed that Rac1, but not Rho or Rap1, induces activation of SGK1. However, this activation was wortmanin insensitive and dominant-negative Rac1 did not inhibit the HGF-mediated activation of SGK1. Adhesion of MDCK cells to immobilized fibronectin also leads to activation of SGK1. However, it appears that the integrin-mediated activation of HA-SGK1 differs from AKT activation in the fact that AKT phosphorylation was blocked by wortmanin (or LY294002) whereas HA-SGK1 was not. The adhesion-dependent activation, however, requires the intact phosphorylation sites of SGK1. Co-transfection of HA-SGK1 with RacV12 results in increased activity in adherent cells compared with HA-SGK1 alone. Since RacN17 failed to inhibit adhesion dependent-activation of SGK1, it suggests that integrin activation is achieved by a parallel Rac-independent pathway.
The activation of SGK1 by HGF and integrin provides a link between HGF-mediated protection of MDCK from de-attachment induced apoptosis (anoikis). We demonstrate that dephosphorylation of the transcription factor FKRHL1 induced by cell de-attachment is prevented by activated SGK1, suggesting that SGK1 regulates cell survival pathways.
In summary, we demonstrate that SGK1 activation could be achieved through signaling pathways involved in the regulation of cell survival, cell-cell and cell-matrix interactions. SGK1 activation can be accomplished via HGF, PI-3K-dependent pathways and by integrin-mediated, PI-3K independent pathways. In addition, activation of SGK1 by the small GTP-binding protein Rac1 has been observed.
Key words: Adhesion, Kinases, MDCK, HGF
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The post-transcriptional regulation of SGK has recently begun to be
described. It has been shown that the subcellular distribution of SGK is
subjected to both cell cycle and hormonal regulation that correlates with the
phosphorylation state of the protein (Buse
et al., 1999), suggesting that SGK expression and activity serves
as an integration point for several signaling pathways. However, the molecular
mechanism that leads to regulation of SGK activity has not been fully
characterized. The structure of SGK shares significant homology with PKA,
PKB/AKT, PKC and p70S6 kinase (Webster et
al., 1993a
; Webster et al.,
1993b
). All of these kinases are subjected to covalent
modification by 3-phosphoinositide-dependent kinase 1, PKD1
(Alessi et al., 1998
;
Cheng et al., 1998
;
Le Good et al., 1998
;
Pullen et al., 1998
;
Vanhaesebroeck and Alessi,
2000
), where the conserved phosphorylation site present in the
activation loop of these kinases (T256 in SGK1) is phosphorylated by PDK1
(Alessi et al., 1998
;
Cheng et al., 1998
;
Le Good et al., 1998
;
Pullen et al., 1998
;
Vanhaesebroeck and Alessi,
2000
). In addition, a phosphorylation site present in a
hydrophobic domain at its C-terminus (S422 in SGK1), the so-called PDK2 site,
is also conserved. The activity of SGK is therefore regulated by the
phosphorylation of these two sites.
Although it is well established that the phosphorylation of SGK at T256 in
the activation loop is carried out by PDK1, the kinase(s) involved in the
phosphorylation of the site at S422 is still poorly defined. The regulation of
AKT via the PDK2 site has been described as accomplished either by a
`modified' PDK1 (Balendran et al.,
1999), an autophosphorylation event
(Toker and Newton, 2000
), or
directly (Delcommenne et al.,
1998
) or indirectly (Lynch et
al., 1999
) by the integrin-linked kinase, ILK. It remains to be
determined whether a similar process regulates SGK activity. However, it is
known that phosphorylation of the S422 is required for maximal activation of
SGK by enhancing phosphorylation of the activation loop residue T256
(Kobayashi and Cohen, 1999
;
Kobayashi et al., 1999
;
Park et al., 1999
). Regulation
of SGK activity by extracellular stimuli, including insulin, insulin-like
growth factor, serum or oxidative stress
(Kobayashi and Cohen, 1999
;
Park et al., 1999
) has been
described. On the basis of these studies carried out by Kobayashi and Cohen
(Kobayashi and Cohen, 1999
), a
model for the activation of SGK has been proposed that involves (1)
IGF-1-induced production of PIP3 that activates a PDK2-like enzyme leading to
phosphorylation of S422 and (2) PDK1 phosphorylation of T256. This model is an
analog of the proposed regulation of p70S6k
(Alessi et al., 1998
;
Pullen et al., 1998
) and
represents an example of a phosphorylation-dependent substrate for PDK1
(Vanhaesebroeck and Alessi,
2000
). Since SGK activity has been described as being regulated by
extracellular stimulation that leads to PI-3K activation, we have investigated
whether SGK activation could be achieved through signaling pathways involved
in the regulation of cell-cell and cell-matrix interactions. We demonstrate
that in the epithelial cell line MDCK, SGK activation can be accomplished via
a scatter-factor-mediated PI-3K-dependent pathway and by an integrin-mediated
PI-3K independent pathway. In addition, activation of SGK by the small
GTP-binding protein Rac1 has been observed.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell culture, transfection and stimulation
MDCK cells were supplied by ATCC (Manassas, VA) and maintained in DMEM/F12
media with 15 mM HEPES and 10% FBS. Transfections were performed using
LipofectAMINE 2000 Reagent according to the manufacturer's protocol (Life
Technologies). Protein expression was confirmed by immunoblotting cell lysates
with antibodies directed to the specific tag used (HA, HAF7; c-myc, 9E10 or
A14) obtained from Santa Cruz Biotechnologies, Inc. (Santa Cruz, CA). Where
indicated, cells were incubated with wortmanin (Calbiochem, La Jolla, CA) (50
nM) in fresh media for 1 hour prior to activation. For HGF stimulation,
transfected cells were incubated overnight in serum-free media containing 0.2%
BSA and stimulated in the presence or absence of wortmanin for 10 minutes with
50 ng/ml HGF (R&D Systems, Minneapolis, MN). For Rac1 experiments, active
Rac1 (RacV12) or dominant-negative Rac1 (RacN17) was cotransfected with SGK1
and left overnight in media with 0.5% FBS prior to the kinase assay. For cAMP
activation, transfected cells were incubated overnight in 0.5% FBS and the
following morning treated with 1 mM 8Bromo-cAMP for 15 minutes before
harvesting. For adhesion-mediated activation, cells were serum-starved
overnight, trypsinized, washed twice and allowed to recover for 1 hour at
37°C in media with 0.2% BSA with or without wortmanin (50 nM) before
plating on fibronectin-coated dishes for the times indicated. Cell extracts
were prepared as previously described
(Herrera, 1998;
Shelly et al., 1998
) and
analyzed for protein expression and kinase activity.
Immunoblots and SGK1 kinase assay
Cell extracts were analyzed by western blot using anti-phospho-AKT (S473)
and anti-AKT (Cell Signaling Technologies, Beverly, MA), anti-phospho-CREB
(Upstate Biotechnology, Lake Placid, NY) antibodies. For kinase assays, cell
extracts were immunoprecipitated with 2 µg of anti-HA (12CA5) antibody
(Roche Molecular Chemicals, Indianapolis, IN) or 1 µg of GFP monoclonal
antibody (Clontech) for 2 hours at 4°C. Immunoprecipitated SGK was washed
in kinase buffer (50 mM HEPES, 10 mM MgCl2, 2.5 mM BME, 0.1%
Triton) before splitting into three aliquots. Kinase assays were performed
with two of the aliquots as described by Park et al.
(Park et al., 1999). Briefly,
40 µl of kinase buffer containing 100 µM ATP, 3 µCuries
(
-32P)-ATP (3000-4000 cpm/pmol) (Amersham Pharmacia Biotech,
Piscataway, NJ) and 10 µg of peptide substrate (KKRNRRLSVA) were added to
the SGK beads and incubated at 30°C for 15 minutes. The reactions were
stopped by adding 100 µl of 100 mM H3PO4, and then 35
µl was spotted onto phosphocellulose squares (Upstate Biotechnologies). The
phosphocellulose squares were washed three times with 100 mM
H3PO4, and the radioactivity was measured using a
scintillation counter. The third aliquot was analyzed for SGK1 expression by
immunoblotting using anti-HA (3F10) (Roche Molecular Chemicals).
Immunoprecipitated GFP-SGK was blotted with anti-SGK (Upstate
Biotechnology).
Immunofluorescence
MDCK cells were plated on two chamber slides (Lab-Tek, Nalgene NUNC
International) and transfected with cDNA expression vectors encoding for
GFP-SGK1, the PH-domain of Akt (Akt/PH-GFP) or pEGFP-C1 (empty vector) with or
without vector encoding for Rac1 V12. After overnight incubation in 0.5% FBS,
the media was replaced and cells were stimulated with HGF (50 ng/ml) for 10
minutes or as indicated in the legend to the figure. The cells were washed and
fixed for 20 minutes in 4% formaldehyde then washed three times before
mounting using Aqua Poly/Mount (Polysciences, Inc., Warrington, PA). Confocal
Microscopy was performed on an Olympus Confocal microscope model IX70.
Adhesion-dependent modulation of FKHRL1 phosphorylation
MDCK cells transfected with either activated SGK1 (S/D) pKH3 or pKH3 (empty
vector) were serum starved overnight. The following morning, the cells were
trypsinized, washed and resuspended in media containing 0.2% BSA and 3 mM
EGTA. Cells were kept in suspension for 1 hour at 37°C (t=1 hour) or lysed
immediately (t=0). Total cell extracts were prepared as described in the
kinase assay section and analyzed for the presence of phosphorylated FKHRL1 by
western analysis. Anti-phospho-FKHRL1 (T32), (Cell Signaling Technologies) and
anti-FKHRL1 (Upstate Biotechnologies) antibodies were used.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
Rac1-V12 activates HA-SGK1
The stimulation of MDCK cells with HGF induces activation of the
Ras/Rac/Rho family of small GTP-binding proteins
(Royal et al., 2000). We
investigated whether cotransfection of activated forms of Rac1, RhoA or Rap1
would lead to HA-SGK1 activation. As shown in
Fig. 2A, cotransfection of
activated Rac1 (Rac1 V12) with HA-SGK1, but not with activated RhoA or Rap1,
resulted in a highly reproducible activation of HA-SGK activity in a
dose-dependent manner (Fig.
2B). Interestingly, the activation observed in response to
Rac1-V12 was not blocked by wortmanin (Fig.
2C) although it still required an intact PDK1 (T256) or PDK2
(S422) phosphorylation site since activation was not observed in a SGK1
protein lacking either or both of these sites (data not shown). We next tested
whether the Rac1 pathway was involved in mediating the HGF activation of SGK1.
We compared the degree of HGF-induced activation of HA-SGK1 upon
contransfection with the dominant-negative form of Rac1 (RacN17)
(Hall, 1998
;
Symons and Settleman, 2000
).
As shown in Fig. 2D,
contransfection of HA-SGK1 with RacN17 did not prevent the activation of
HA-SGK by HGF. On the other hand, cotransfection of activated Rac1 with
HA-SGK1 leads to increased activation upon stimulation with HGF as compared
with the activity obtained in the presence of activated Rac1 alone or HGF
stimulation in the absence of activated Rac1 (data not shown).
|
Analysis of the primary structure of SGK1 reveals the presence of other
potential phosphorylation sites such as a tyrosine kinase site (Y124) and a
PKA site (T369). We analyzed whether activation of SGK1 results in tyrosine
phosphorylation and whether the potential PKA site is a functional regulatory
site. We failed to detect tyrosine phosphorylation of HA-SGK1 in response to
HGF treatment. Similarly, we were unable to demonstrate a significant
activation of HA-SGK1 by cAMP stimulation under conditions where we detect
cAMP-mediated phosphorylation of the transcription factor CREB
(Fig. 3). In addition, we
mutated the potential PKA site and tested its role in the activation of
HA-SGK1 in response to stimulation. Changing the potential PKA phosphorylation
site to alanine produced an active protein that was still responsive to HGF or
Rac1 V12. The level of activation of T369A mutant enzyme by Rac1 V12 or HGF
was consistently only 75% of that the wild-type enzyme. While this work was
being carried out, a report was published
(Perrotti et al., 2001)
describing cAMP regulation of SGK activity with results that are different
from those that we describe above. The reason for these discrepancies is
currently not clear.
|
We constructed a GFP-SGK1 fusion protein in order to study whether
activation of SGK1 by HGF or RacV12 correlates with subcellular translocation.
We compared GFP-SGK1 movement with that of the GFP-PH/AKT fusion protein,
which is a marker for membrane recruitment
(Raucher et al., 2000). As
shown in Fig. 4A, the GFP-SGK1
fusion protein is expressed as a full-length, kinase-active protein in
transfected MDCK cells. Treatment of GFP-SGK1- or GFP-PH/AKT-transfected cells
with either HGF or cotransfection with RacV12 induces recruitment of the
GFP-PH/AKT protein to the intercellular surfaces
(Fig. 4B), indicating that
activation of PI-3K has taken place. The GFP-SGK1 protein, by contrast, is not
significantly recruited to the same structures, suggesting that HGF-and
RacV12-mediated activation of SGK1 does not involve significant subcellular
redistribution.
|
Adhesion-dependent activation of SGK1
It has previously been demonstrated that cell adhesion to the extracellular
matrix via integrins induces activation of AKT
(Banfic et al., 1998;
Guilherme and Czech, 1998
).
Thus, we were interested in determining whether adhesion of MDCK cells to
fibronectin would result in activation of transfected HA-SGK1. We measured and
compared the kinase activity of SGK1 isolated from suspended and attached
cells. We also followed the endogenous activation of AKT by monitoring its
phosphorylation at S473.
Time course analysis of the activation of SGK1 upon interaction of MDCK
cells with immobilized fibronectin showed that adhesion of the cells to the
extracellular matrix induces a prolonged activation of SGK1
(Fig. 5A). The activation
profile followed the spreading of the cells (data not shown). As previously
reported (King et al., 1997),
the adhesion of the cells also leads to AKT activation
(Fig. 5B). However, it appears
that the integrin-mediated activation of HA-SGK1 differs from AKT activation
in that AKT phosphorylation was blocked by wortmanin (or LY294002). Although
the basal activity of HA-SGK1 in the presence of wortmanin is reduced, the
fold of activation was not (Fig.
5C,D). Similarly, LY294002 did not reduce the fold activation of
SGK1 despite strong inhibition of AKT phosphorylation (data not shown).
|
Integrin-mediated activation of HA-SGK1 requires the intact phosphorylation sites that regulate HA-SGK1 activation in response to HGF or Rac 1-V12. We therefore assessed the role of Rac1 in integrin-mediated activation of SGK1. Cotransfection of HA-SGK with dominant-negative Rac1 (RacN17) did not result in inhibition of adhesion-stimulated activation of SGK1 (Fig. 6). The RacN17 is acting as a true dominant negative in this system since it blocked the HGF-stimulated actin reorganization (data not shown). Cotransfection of HA-SGK1 with RacV12 results in increased activity in adherent cells compared with the effect of transfection of HA-SGK1 alone. The binding of cotransfected cells to fibronectin resulted in a greater activation than is obtained in the absence of RacV12, indicating that the adhesion-dependent activation is achieved by a parallel Rac-independent pathway (Fig. 6).
|
Activated SGK1 prevents de-attachment-induced dephosphorylation of
FKHRL1
The activation of SGK1 by integrin or HGF may be connected to the
modulation of cell survival. HGF activates an anti-apoptotic pathway
(Bardelli et al., 1996) and
blocks apoptosis of MDCK cells induced by loss of integrin-mediated cell
attachment (anoikis) (Frisch and Francis,
1994
), suggesting that both HGF and integrin signaling share a
common pathway. We investigated whether the phosphorylation state of FKHRL1, a
known modulator of cell survival (Liu et
al., 2000
), was regulated by cell attachment and whether this
regulation could be influenced by SGK1. As shown in
Fig. 7, deattachment of MDCK
cells leads to a rapid loss of phosphorylated FKHRL1 (compare lanes 1-4 with
lanes 7,8).
|
However, the presence of activated SGK1 prevented the dephosphorylation of
FKHRL1 during the incubation period, suggesting that activated SGK1 provides
survival signals similar to the one described for Akt
(Brunet et al., 1999).
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The role of SGK in signal transduction is poorly defined. However, as it
belongs to the AGC class of kinases, its activity is regulated by PDK1,
suggesting that it may participate in some of the pathways under the control
of PI-3K (Currie et al., 1999;
Czech, 2000
;
Kobayashi and Cohen, 1999
;
Park et al., 1999
;
Vanhaesebroeck and Alessi,
2000
; Williams et al.,
2000
). Accordingly, it has been suggested that SGK participates in
the regulation of GSK-3 (Kobayashi and
Cohen, 1999
) and that it functionally replaces the Ypk1
gene in budding yeast (Casamayor et al.,
1999
). On the other hand, it is also evident from the data
presented in this paper that SGK1 activation can be accomplished by signaling
pathways that are independent of PI-3K activation. While this paper was in
preparation, a report describing activation of SGK by ERK5 independently of
PDK1-mediated activation was published (Hayashi, 2001).
We analyzed the activation profiles of AKT and SGK upon stimulation with
agonists or signaling intermediaries in order to compare the mechanism of
activation of these two members of the AGC kinase family. As described in the
Results section, we demonstrated that treatment of MDCK cells with HGF induces
activation of both AKT and SGK in a PI-3K-dependent manner
(Fig. 1A-C;
Table 1). However, in contrast
to HGF-mediated activation of SGK1, activation of SGK by RacV12 was shown to
be wortmanin insensitive, suggesting that RacV12 activation does not require
activation of PI-3K (Fig.
2A-C). It has been shown that Rac1-mediated activation of AKT in T
cells requires PI-3K activity (Genot et
al., 2000). It remains to be determined whether Rac1 activates AKT
in MDCK cells and whether it is PI-3K independent as has been reported for the
activation of AKT by cAMP (Filippa et al.,
1999
). We analyzed the possibility that cAMP also activates SGK,
as treatment of granulosa cells with forskolin induces SGK phosphorylation
(Gonzalez-Robayna et al.,
2000
). We observed the presence of a potential PKA site in SGK and
mutated it to measure its contribution to SGK activation. Unlike researchers
in previous reports (Perrotti et al.,
2001
), we failed to demonstrate cAMP-mediated activation of SGK
under conditions that lead to phosphorylation of CREB
(Fig. 3).
Our analysis of adhesion-dependent activation of SGK revealed that adhesion
of MDCK cells to fibronectin activates SGK in a wortmanin-independent manner.
This is in contrast to observations for AKT activation under the same
conditions (Fig. 5A-C).
Integrin-mediated activation of SGK was not inhibited by the neutralization of
Rac activation. Indeed, we saw an additive activation mediated by RacV12 and
fibronectin adhesion, indicating that there are other pathways that lead to
SGK activation. Significantly, the activation of SGK is still under the
structural requirements that regulate PDK1 activation of SGK, since mutations
in the PDK1 or PDK2 sites produce an inactive SGK protein. There are
conditions, however, in which PDK1 activity does not require input from the
PI-3K pathway (Vanhaesebroeck and Alessi,
2000), thus explaining the need for the PDK1 site without
requiring activation of PI-3K.
The regulation of SGK activity in MDCK cells by both HGF and cell adhesion
suggests that SGK may participate in signaling pathways that modulate cell
motility. However, recently published information
(Brunet et al., 2001;
Liu et al., 2000
) points to a
functional role for SGK that is complementary to the role that AKT plays in
promoting cell survival by directly phosphorylating and inactivating the
proapoptotic proteins FKHR and BAD (Brunet
et al., 1999
). Here we have shown that SGK1 also mediates
signaling associated with cell survival. The activation of SGK1 by HGF or
integrin may connect this protein to the protection of MDCK from anoikis since
the deattachment-induced dephosphorylation of FKHRL1 is significantly reduced
by expression of activated SGK1 (Fig.
7).
In conclusion, we present experimental evidence that SGK1 activation can be accomplished via HGF, PI-3K-dependent pathways and by integrin-mediated, PI-3K-independent pathways. In addition, activation of SGK1 by the small GTP-binding protein Rac1 has been observed. These results suggest that activation of SGK1 could be achieved through signaling pathways involved in the regulation of cell survival, cell-cell and cell-matrix interactions.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Alessi, D. R., Kozlowski, M. T., Weng, Q. P., Morrice, N. and Avruch, J. (1998). 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8,69 -81.[Medline]
Alliston, T. N., Maiyar, A. C., Buse, P., Firestone, G. L. and
Richards, J. S. (1997). Follicle stimulating
hormone-regulated expression of serum/glucocorticoid-inducible kinase in rat
ovarian granulosa cells: a functional role for the Sp1 family in promoter
activity. Mol. Endocrinol.
11,1934
-1949.
Alvarez de la Rosa, D., Zhang, P., Naray-Fejes-Toth, A.,
Fejes-Toth, G. and Canessa, C. M. (1999). The serum and
glucocorticoid kinase sgk increases the abundance of epithelial sodium
channels in the plasma membrane of Xenopus oocytes. J.
Biol. Chem. 274,37834
-37839.
Balendran, A., Casamayor, A., Deak, M., Paterson, A., Gaffney, P., Currie, R., Downes, C. P. and Alessi, D. R. (1999). PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol. 9, 393-404.[Medline]
Banfic, H., Downes, C. P. and Rittenhouse, S. E.
(1998). Biphasic activation of PKBalpha/Akt in platelets.
Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate,
produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate.
J. Biol. Chem. 273,11630
-11637.
Bardelli, A., Longati, P., Albero, D., Goruppi, S., Schneider, C., Ponzetto, C. and Comoglio, P. M. (1996). HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 15,6205 -6212.[Abstract]
Bell, L. M., Leong, M. L., Kim, B., Wang, E., Park, J.,
Hemmings, B. A. and Firestone, G. L. (2000). Hyperosmotic
stress stimulates promoter activity and regulates cellular utilization of the
serum- and glucocorticoid-inducible protein kinase (Sgk) by a p38
MAPK-dependent pathway. J. Biol. Chem.
275,25262
-25272.
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96,857 -868.[Medline]
Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A. and
Greenberg, M. E. (2001). Protein kinase SGK mediates survival
signals by phosphorylating the Forkhead transcription factor FKHRL1 (FOXO3a).
Mol. Cell. Biol. 21,952
-965.
Buse, P., Trans, S. H., Luther, E., Phu, P. T., Aponte, G. W.
and Firestone, G. L. (1999). Cell cycle and hormonal control
of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible
protein kinase, Sgk, in mammary tumor cells. A novel convergence point of
anti-proliferative and proliferative cell signaling pathways. J.
Biol. Chem. 274,7253
-7263.
Casamayor, A., Torrance, P. D., Kobayashi, T., Thorner, J. and Alessi, D. R. (1999). Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast. Curr. Biol. 9,186 -197.[Medline]
Chen, S. Y., Bhargava, A., Mastroberardino, L., Meijer, O. C.,
Wang, J., Buse, P., Firestone, G. L., Verrey, F. and Pearce, D.
(1999). Epithelial sodium channel regulated by
aldosterone-induced protein sgk. Proc. Natl. Acad. Sci.
USA 96,2514
-2519.
Cheng, X., Ma, Y., Moore, M., Hemmings, B. A. and Taylor, S.
S. (1998). Phosphorylation and activation of cAMP-dependent
protein kinase by phosphoinositide-dependent protein kinase. Proc.
Natl. Acad. Sci. USA 95,9849
-9854.
Coulonval, K., Vandeput, F., Stein, R. C., Kozma, S. C., Lamy, F. and Dumont, J. E. (2000). Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin. Biochem. J. 348,351 -358.[Medline]
Currie, R. A., Walker, K. S., Gray, A., Deak, M., Casamayor, A., Downes, C. P., Cohen, P., Alessi, D. R. and Lucocq, J. (1999). Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem. J. 337,575 -583.[Medline]
Czech, M. P. (2000). PIP2 and PIP3: complex roles at the cell surface. Cell 100,603 -606.[Medline]
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J. and
Dedhar, S. (1998). Phosphoinositide-3-OH kinase-dependent
regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the
integrin-linked kinase. Proc. Natl. Acad. Sci. USA
95,11211
-11216.
Filippa, N., Sable, C. L., Filloux, C., Hemmings, B. and Van
Obberghen, E. (1999). Mechanism of protein kinase B
activation by cyclic AMP-dependent protein kinase. Mol. Cell
Biol. 19,4989
-5000.
Frisch, S. M. and Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124,619 -626.[Abstract]
Genot, E. M., Arrieumerlou, C., Ku, G., Burgering, B. M., Weiss,
A. and Kramer, I. M. (2000). The T-cell receptor regulates
Akt (protein kinase B) via a pathway involving Rac 1 and phosphatidylinositide
3-kinase Mol. Cell Biol.
20,5469
-5478.
Gonzalez-Robayna, I. J., Falender, A. E., Ochsner, S.,
Firestone, G. L. and Richards, J. S. (2000).
Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation
of protein kinase B (PKB/Akt) and serum and glucocorticoid-Induced kinase
(Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.
Mol. Endocrinol. 14,1283
-1300.
Guilherme, A. and Czech, M. P. (1998).
Stimulation of IRS-1-associated phosphatidylinositol 3-kinase and Akt/protein
kinase B but not glucose transport by beta 1-integrin signaling in rat
adipocytes. J. Biol. Chem.
273,33119
-33122.
Hall, A. (1998). Rho GTPases and the actin
cytoskeleton. Science
279,509
-514.
Herrera, R. (1998). Modulation of hepatocyte
growth factor-induced scattering of HT29 colon carcinoma cells. Involvement of
the MAPK pathway. J. Cell Sci.
111,1039
-1049.
Khwaja, A., Lehmann, K., Marte, B. M. and Downward, J.
(1998). Phosphoinositide 3-kinase induces scattering and
tubulogenesis in epithelial cells through a novel pathway. J. Biol.
Chem. 273,18793
-18801.
King, W. G., Mattaliano, M. D., Chan, T. O., Tsichlis, P. N. and Brugge, J. S. (1997). Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17,4406 -4418.[Abstract]
Kobayashi, T. and Cohen, P. (1999). Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phospoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem. J. 339,319 -328.[Medline]
Kobayashi, T., Deak, M., Morrice, N. and Cohen, P. (1999). Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase. Biochem. J. 344,189 -197.[Medline]
Lang, F., Klingel, K., Wagner, C. A., Stegen, C., Warntges, S.,
Friedrich, B., Lanzendorfer, M., Melzig, J., Moschen, I., Steuer, S. et
al. (2000). Deranged transcriptional regulation of
cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc.
Natl. Acad. Sci. USA 97,8157
-8162.
Le Good, J. A., Ziegler, W. H., Parekh, D. B., Alessi, D. R.,
Cohen, P. and Parker, P. J. (1998). Protein kinase C isotypes
controlled by phosphoinositide 3-kinase through the protein kinase PDK1.
Science 281,2042
-2045.
Liu, D., Yang, X. and Songyang, Z. (2000). Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr. Biol. 10,1233 -1236.[Medline]
Liu, Y. (1999). Hepatocyte growth factor
promotes renal epithelial cell survival by dual mechanisms. Am. J.
Physiol. 277,F624
-F633.
Lynch, D. K., Ellis, C. A., Edwards, P. A. and Hiles, I. D. (1999). Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18,8024 -8032.[Medline]
Maiyar, A. C., Huang, A. J., Phu, P. T., Cha, H. H. and
Firestone, G. L. (1996). p53 stimulates promoter activity of
the sgk. Serum/glucocorticoid-inducible serine/threonine protein kinase gene
in rodent mammary epithelial cells. J. Biol. Chem.
271,12414
-12422.
Hayashi, M., Tapping, R. I., Chao, T. H., Lo, J.-F., King, C.
C., Yang, Y. and Lee, J. D. (2001). BMK1 mediates growth
factor-induced cell proliferation through direct cellular activation of SGK.
J. Biol. Chem. 276,8631
-8634.
Park, J., Leong, M. L., Buse, P., Maiyar, A. C., Firestone, G.
L. and Hemmings, B. A. (1999). Serum and
glucocorticoid-inducible kinase (SGK) is a target of the PI
3-kinase-stimulated signaling pathway. EMBO J.
18,3024
-3033.
Perrotti, N., He, R. A., Phillips, S. A., Renfrew Haft, C. and
Taylor, S. I. (2001). Activation of serum- and
glucocorticoid-induced protein kinase (SGK) by cyclic AMP and insulin.
J. Biol. Chem. 276,9406
-9412.
Potempa, S. and Ridley, A. J. (1998).
Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is
required for hepatocyte growth factor/scatter factor-induced adherens junction
disassembly. Mol. Biol. Cell
9,2185
-2200.
Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma,
S. C., Hemmings, B. A. and Thomas, G. (1998). Phosphorylation
and activation of p70s6k by PDK1. Science
279,707
-710.
Raucher, D., Stauffer, T., Chen, W., Shen, K., Guo, S., York, J. D., Sheetz, M. P. and Meyer, T. (2000). Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell 100,221 -228.[Medline]
Royal, I., Lamarche-Vane, N., Lamorte, L., Kaibuchi, K. and
Park, M. (2000). Activation of cdc42, rac, PAK, and
rho-kinase in response to hepatocyte growth factor differentially regulates
epithelial cell colony spreading and dissociation. Mol. Biol.
Cell 11,1709
-1725.
Shelly, C., Petruzzelli, L. and Herrera, R. (1998). PMA-induced phenotypic changes in K562 cells: MAPK-dependent and -independent events. Leukemia 12,1951 -1961.[Medline]
Stoker, M., Gherardi, E., Perryman, M. and Gray, J. (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327,239 -242.[Medline]
Symons, M. and Settleman, J. (2000). Rho family GTPases: more than simple switches. Trends Cell Biol. 10,415 -419.[Medline]
Toker, A. and Newton, A. C. (2000). Akt/protein
kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site.
J. Biol. Chem. 275,8271
-8274.
Vanhaesebroeck, B. and Alessi, D. R. (2000). The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346,561 -576.[Medline]
Wagner, C. A., Broer, A., Albers, A., Gamper, N., Lang, F. and
Broer, S. (2000). The heterodimeric amino acid transporter
4F2hc/LAT1 is associated in Xenopus oocytes with a non-selective
cation channel that is regulated by the serine/threonine kinase sgk-1.
J. Physiol. (Lond.) 526,35
-46.
Waldegger, S., Barth, P., Raber, G. and Lang, F.
(1997). Cloning and characterization of a putative human
serine/threonine protein kinase transcriptionally modified during anisotonic
and isotonic alterations of cell volume. Proc. Natl. Acad. Sci.
USA 94,4440
-4445.
Webster, M. K., Goya, L. and Firestone, G. L.
(1993a). Immediate-early transcriptional regulation and rapid
mRNA turnover of a putative serine/threonine protein kinase. J.
Biol. Chem. 268,11482
-11485.
Webster, M. K., Goya, L., Ge, Y., Maiyar, A. C. and Firestone, G. L. (1993b). Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol. Cell Biol. 13,2031 -2040.[Abstract]
Weidner, K. M., Behrens, J., Vandekerckhove, J. and Birchmeier, W. (1990). Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111,2097 -2108.[Abstract]
Weidner, K. M., Hartmann, G., Sachs, M. and Birchmeier, W. (1993). Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met. Am. J. Respir. Cell. Mol. Biol. 8,229 -237.[Medline]
Williams, M. R., Arthur, J. S., Balendran, A., van der Kaay, J., Poli, V., Cohen, P. and Alessi, D. R. (2000). The role of 3-phosphoinositide-dependent protein kinase 1 in a ctivating AGC kinases defined in embryonic stem cells. Curr. Biol. 10,439 -448.[Medline]
Xiao, G. H., Jeffers, M., Bellacosa, A., Mitsuuchi, Y., Vande
Woude, G. F. and Testa, J. R. (2001). Anti-apoptotic
signaling by hepatocyte growth factor/Met via the phosphatidylinositol
3-kinase/Akt and mitogen-activated protein kinase pathways. Proc.
Natl. Acad. Sci. USA 98,247
-252.